Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kevin Malone

Hand Surgery Cleveland, OH Medical Doctor

NPI 1881794691 CMS profile 84912

11100 Euclid Ave Dept Of, Cleveland, OH 44106

Open in the dashboard

General payments

$39,264

94 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kevin Malone of Cleveland, OH is reported in the CMS Open Payments database as having received $39,264 across 94 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,183 26
2024 General $4,518 8
2023 General $5,774 12
2022 General $6,044 12
2021 General $2,063 6
2020 General $7,877 23
2019 General $3,807 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Malone
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Kevin Malone were reported at $9,183. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Kevin Malone Hand Surgery median Middle half National median
2019 $3,807 $383 $106–$1,905 $163
2020 $7,877 $172 $51–$1,268 $114
2021 $2,063 $263 $71–$1,591 $132
2022 $6,044 $336 $87–$1,938 $149
2023 $5,774 $233 $81–$1,114 $160
2024 $4,518 $258 $88–$1,203 $164
2025 $9,183 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Synthes GmbH $36,944 58 payments
  2. Rock Medical Orthopedics, Inc. $790 1 payment
  3. Stryker Corporation $419 15 payments
  4. Checkpoint Surgical, Inc $295 3 payments
  5. AxoGen $255 2 payments
  6. Tulavi Therapeutics, Inc. $196 1 payment
  7. Acumed LLC $176 4 payments
  8. Bioventus LLC $95 5 payments
  9. Flexion Therapeutics, Inc. $85 4 payments
  10. Arthrosurface Incorporated $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $16,050 14 payments
  2. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $9,500 20 payments
  3. Travel and Lodging $7,392 16 payments
  4. Consulting Fee $3,250 2 payments
  5. Food and Beverage $2,252 38 payments
  6. Education $820 4 payments
Products named General payments · program years 2019–2025
  1. Checkpoint Stimulators $295 3 payments
  2. Avance Nerve Graft $216 1 payment
  3. AxoGuard Nerve Connector $216 1 payment
  4. AXOGUARD NERVE PROTECTOR $216 1 payment
  5. Axoguard HA+ Nerve Protector $216 1 payment
  6. AXOGUARD NERVE CAP $216 1 payment
  7. ALLAY NERVE CAP - SMALL NERVE SET $196 1 payment
  8. ACUMED $176 4 payments
  9. PROFYLE $128 1 payment
  10. PANGEA $100 2 payments
  11. Other $475 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

205

Median for Orthopedic Surgery: 203

Drug cost

$933

Median for Orthopedic Surgery: $1,433

Branded share of claims

48.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 99 $473
Oxycodone Hcl Generic 65 $282
Tramadol Hcl Generic 16 $90
Methylprednisolone Generic 14 $69
Meloxicam Generic 11 $19

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$112,040

Of which drugs: $461

Medicare patients

516

Average age 75

Services billed

2,090

300 women, 216 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 71%
High blood pressure 70%
Ischemic heart disease 27%
Diabetes 21%
Chronic kidney disease 19%
Cancer 18%
Depression 18%
Osteoporosis 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 149 643 $461

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

94 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record